Medical Care Technologies Continues Rigorous Testing of MDCE Melanoma Scan While Evaluating Expansion Opportunities (OTC Pink:MDCE)

Rhea-AI Summary

Medical Care Technologies (OTC Pink: MDCE) reported ongoing rigorous testing of its MDCE Melanoma Scan Beta AI imaging platform as of August 3, 2026. The company is conducting structured evaluation and model training using multi-phase testing protocols that emphasize image quality, consistency, and performance across varied datasets, aiming to refine its proprietary AI vision systems.

In parallel, Medical Care Technologies continues to operate a diversified business model with revenue-generating subsidiaries and consumer applications. The company is evaluating selective partnerships and potential brand acquisitions aligned with its software development, AI vision, and digital platform capabilities, while seeking to balance technical development, monetization, and strategic growth.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Company Maintains Active Development of Core AI Imaging Technology Alongside Diversified Revenue Platforms and Strategic Growth Considerations

MESA, AZ / ACCESS Newswire / August 3, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today provided an update on the continued rigorous testing of its MDCE Melanoma Scan Beta platform and the Company's broader expansion outlook.

The Company remains actively engaged in structured evaluation and model training for MDCE Melanoma Scan Beta, applying multi-phase testing protocols focused on image quality, consistency, and performance across varied datasets. These efforts form part of MDCE's ongoing commitment to technical refinement of its proprietary AI vision systems.

In parallel, Medical Care Technologies continues to operate a diversified model that includes revenue-generating subsidiaries and consumer applications. The Company is also evaluating opportunities to expand through selective partnerships and potential brand acquisitions that align with its software development, AI vision, and digital platform capabilities.

"We are maintaining disciplined progress on MDCE Melanoma Scan while building commercial strength across our broader technology portfolio," said Marshall Perkins, CEO of Medical Care Technologies. "Our diversified approach allows us to generate revenue from existing platforms even as we advance core medical imaging tools and explore measured expansion opportunities."

Medical Care Technologies remains focused on balancing rigorous technical development with practical monetization and strategic growth initiatives.

About Medical Care Technologies Inc. Medical Care Technologies Inc. (OTC Pink: MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. The Company also owns subsidiaries Infinite Auctions and Real Game Used, which provide complementary revenue-generating operations. Visit: https://medicalcaretechnologies.com

About Infinite Auctions Infinite Auctions is a wholly-owned subsidiary of Medical Care Technologies Inc. specializing in premium sports memorabilia auctions through its innovative online platform. Visit: https://infiniteauctions.com

About Real Game Used Real Game Used is a wholly-owned subsidiary of Medical Care Technologies Inc. specializing in AI-enhanced photo match authentication for sports and entertainment memorabilia. Visit: https://realgameused.com

Safe Harbor Statement This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.

Contact Information: Medical Care Technologies Inc. 1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204 Phone: +1 (480) 645-0750 Email: info@infiniteauctions.com Websites: https://medicalcaretechnologies.com | https://infiniteauctions.com | https://realgameused.com

SOURCE: Medical Care Technologies Inc.

View the original press release on ACCESS Newswire

FAQ

What is MDCE Melanoma Scan Beta and how is Medical Care Technologies (OTC Pink:MDCE) testing it in 2026?

MDCE Melanoma Scan Beta is an AI-driven melanoma imaging platform undergoing multi-phase testing. According to Medical Care Technologies, the system is in structured evaluation and model training focused on image quality, consistency, and performance across diverse datasets to refine its proprietary AI vision technology.

What expansion opportunities is Medical Care Technologies (MDCE) evaluating as of August 3, 2026?

Medical Care Technologies is evaluating selective partnerships and potential brand acquisitions aligned with its AI vision and digital platform capabilities. According to the company, these opportunities are considered alongside its existing software development and diversified revenue platforms to support measured, strategically aligned growth initiatives.

How does Medical Care Technologies (OTC Pink:MDCE) generate revenue while developing MDCE Melanoma Scan?

Medical Care Technologies generates revenue through diversified subsidiaries and consumer applications while progressing MDCE Melanoma Scan. According to the company, its wholly-owned subsidiaries Infinite Auctions and Real Game Used provide complementary, revenue-generating operations that support broader technology development and commercial strength.

What does Infinite Auctions contribute to Medical Care Technologies (MDCE)?

Infinite Auctions is a wholly-owned subsidiary specializing in premium sports memorabilia auctions via an online platform. According to Medical Care Technologies, Infinite Auctions operates as a revenue-generating business that complements the company’s broader AI-powered application portfolio and diversified technology strategy.

What is Real Game Used within the Medical Care Technologies (MDCE) portfolio?

Real Game Used is a wholly-owned subsidiary focused on AI-enhanced photo match authentication for sports and entertainment memorabilia. According to Medical Care Technologies, this business provides complementary revenue-generating operations within its diversified technology model and supports its AI vision and imaging capabilities.

What is the core business focus of Medical Care Technologies (OTC Pink:MDCE) in 2026?

Medical Care Technologies focuses on developing and commercializing artificial intelligence-powered applications in health, wellness, nutrition, lifestyle, and enterprise imaging. According to the company, this includes MDCE Melanoma Scan and digital platforms supported by revenue-generating subsidiaries Infinite Auctions and Real Game Used.